Case Report

Published on 31 Jul 2024

A case report: Pathological complete response to neoadjuvant lorlatinib for Epithelioid inflammatory myofibroblastic sarcoma with EML4-ALK rearrangement

in Pharmacology of Anti-Cancer Drugs

Yang Zheng
Fanfei Zhao
Yaqian Ren
Yaran Xue
Bing Yan
Chun Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1401428

756 views

Review

Published on 31 Jul 2024

Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment

in Pharmacology of Anti-Cancer Drugs

Yuxuan Tu
Jianbao Gong
Jing Mou
Hongfei Jiang
Haibo Zhao
Jiake Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1434137

1,194 views
2 citations

Systematic Review

Published on 30 Jul 2024

Past and present: a bibliometric study on the treatment of recurrent ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Xiao-yuan Hao
Wen-wei Song
Miao-ling Li
Yi Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1442022

934 views

Original Research

Published on 29 Jul 2024

Prognostic impact of metformin in solid cancer patients receiving immune checkpoint inhibitors: novel evidences from a multicenter retrospective study

in Pharmacology of Anti-Cancer Drugs

Jiaxin Wang
Jie Lin
Huaijuan Guo
Wenjuan Wu
Jingjing Yang
Jingxian Mao
Wenbin Fan
Hong Qiao
Ying Wang
Xuebing Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1419498

1,498 views

Case Report

Published on 29 Jul 2024

Case report: Durable response of ensartinib targeting EML4-ALK fusion in osimertinib-resistant non-small cell lung cancer

in Pharmacology of Anti-Cancer Drugs

Yongkuan Guo
Ran Zhang
Yiran Meng
Li Wang
Liuqing Zheng
Jian You

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1359403

1,124 views
2 citations

Correction

Published on 29 Jul 2024

Corrigendum: Methotrexate-conjugated zinc oxide nanoparticles exert substantially improved cytotoxic effect on lung cancer cells by inducing apoptosis

in Pharmacology of Anti-Cancer Drugs

Prakriti Mishra
Mohammad Faizan Ali Ahmad
Lamya Ahmed Al-Keridis
Mohd Saeed
Nawaf Alshammari
Nadiyah M. Alabdallah
Rohit Kumar Tiwari
Afza Ahmad
Mahima Verma
Shireen Fatima

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1423402

468 views

Review

Published on 26 Jul 2024

The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies

in Pharmacology of Anti-Cancer Drugs

Jiaqi Ren
Linlin Lv
Xufeng Tao
Xiaohan Zhai
Xuyang Chen
Hao Yu
Xinya Zhao
Xin Kong
Zhan Yu
Deshi Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432545

1,465 views
1 citation

Original Research

Published on 26 Jul 2024

A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases

in Pharmacology of Anti-Cancer Drugs

Yunlin Jiang
Taihang Shao
Mingye Zhao
Yahong Xue
Xueping Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1374136

1,119 views

Systematic Review

Published on 26 Jul 2024

First-line immune checkpoint inhibitors in low programmed death-ligand 1-expressing population

in Pharmacology of Anti-Cancer Drugs

Feiyang Zhang
Guoming Chen
Yixin Yin
Xiaojiang Chen
Runcong Nie
Yingbo Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377690

1,315 views

Original Research

Published on 25 Jul 2024

Identification of potential inhibitors for drug-resistant EGFR mutations in non-small cell lung cancer using whole exome sequencing data

in Pharmacology of Anti-Cancer Drugs

Nagasundaram Nagarajan
Chittibabu Guda

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1428158

1,170 views

Original Research

Published on 25 Jul 2024

Promotion of tumor angiogenesis and growth induced by low-dose antineoplastic agents via bone-marrow-derived cells in tumor tissues

in Pharmacology of Anti-Cancer Drugs

Huining You
Peipei Zhao
Xue Zhao
Qiaowei Zheng
Wenbing Ma
Kai Cheng
Min Li
Jianrong Kou
Weiyi Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1414832

664 views

Original Research

Published on 25 Jul 2024

The SAR analysis of dietary polyphenols and their antagonistic effects on bortezomib at physiological concentrations

in Pharmacology of Anti-Cancer Drugs

Tran Tran Thi Van
Hsun-Shuo Chang
Ho-Cheng Wu
Chung-Kuang Lu
Hui-Chi Huang
Michal Korinek
Hui-Hua Hsiao
Chia-Hung Yen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403424

812 views

Original Research

Published on 24 Jul 2024

Crotoxin induces cytotoxic effects in human malignant melanoma cells in both native and detoxified forms

in Pharmacology of Anti-Cancer Drugs

Tamires Cunha Almeida
Karina Cristina Giannotti
Lorena Morais Ribeiro Silva
Rafael Marques-Porto
Carlos DeOcesano-Pereira
Lauren Camargo
Ana Marisa Chudzinski-Tavassi
Paul Reid
Gisele Picolo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1425446

788 views

Original Research

Published on 24 Jul 2024

CBX2 enhances the progression and TMZ chemoresistance of glioma via EZH2-mediated epigenetic silencing of PTEN expression

in Pharmacology of Anti-Cancer Drugs

Jian Wang
Bo Yang
Yingzhao Wang
Shuhan Liu
Changkai Ma
Jianmin Piao
Shiqiang Ma
Dehai Yu
Wei Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1430891

966 views

Mini Review

Published on 24 Jul 2024

Research progress on nonsteroidal anti-inflammatory drugs in the treatment of pituitary neuroendocrine tumors

in Pharmacology of Anti-Cancer Drugs

Jiaqi Li
Xinkang Shi
Tao Tang
Manxin Zhou
Feng Ye

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407387

674 views

Original Research

Published on 24 Jul 2024

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib

in Pharmacology of Anti-Cancer Drugs

Xusheng Zhang
Xiuli Ren
Tianyu Zhu
Wanjin Zheng
Chengwu Shen
Cuicui Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1407709

1,562 views

Navigation group

Articles

A case report: Pathological complete response to neoadjuvant lorlatinib for Epithelioid inflammatory myofibroblastic sarcoma with EML4-ALK rearrangement

Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment

Past and present: a bibliometric study on the treatment of recurrent ovarian cancer

Prognostic impact of metformin in solid cancer patients receiving immune checkpoint inhibitors: novel evidences from a multicenter retrospective study

Case report: Durable response of ensartinib targeting EML4-ALK fusion in osimertinib-resistant non-small cell lung cancer

Corrigendum: Methotrexate-conjugated zinc oxide nanoparticles exert substantially improved cytotoxic effect on lung cancer cells by inducing apoptosis

The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies

A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases

First-line immune checkpoint inhibitors in low programmed death-ligand 1-expressing population

Identification of potential inhibitors for drug-resistant EGFR mutations in non-small cell lung cancer using whole exome sequencing data

Promotion of tumor angiogenesis and growth induced by low-dose antineoplastic agents via bone-marrow-derived cells in tumor tissues

The SAR analysis of dietary polyphenols and their antagonistic effects on bortezomib at physiological concentrations

Crotoxin induces cytotoxic effects in human malignant melanoma cells in both native and detoxified forms

CBX2 enhances the progression and TMZ chemoresistance of glioma via EZH2-mediated epigenetic silencing of PTEN expression

Research progress on nonsteroidal anti-inflammatory drugs in the treatment of pituitary neuroendocrine tumors

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib